In contrast, strong monotherapy antitumor activity was observed in mice treated with Fc-effector anti-CTLA4 (figure 5A, B) consistent with prior reports.15 Treatment with monotherapy anti-PD-1 provided partial tumor growth inhibition. This evidence concerns the gene PDCD1 and neoplasm.